Oxygen Supplementation and Hyperoxia in Critically Ill Cardiac Patients
Seminars in Respiratory and Critical Care Medicine · 22.09.2026
DOI: 10.1055/a-2960-4026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Seminars in Respiratory and Critical Care Medicine, erschienen am 22.09.2026. Verfasst von Antonio Campanella und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hospital F. Spaziani, Department of Anesthesia and Intensive Care, Lazio, Italy, Frosinone. Die Arbeit nennt 71 Literaturangaben. Gefördert von: ERAPerMed, Instituto de Salud Carlos III, Madrid, Spain, European Regional Development Funds, Fundación Canaria Instituto de Investigación Sanitaria de Canarias, Spain.
Abstract (Originalsprache)
Oxygen therapy is essential in critically ill cardiac patients, but its use requires careful titration. Hypoxemia (as defined by an oxygen partial pressure/fraction of inspired oxygen [PaO2/FiO2] < 300) can worsen myocardial ischemia, precipitate arrhythmias, aggravate shock, and contribute to secondary neurological injury after cardiac arrest. Conversely, unnecessary hyperoxemia may increase oxidative stress, promote coronary and systemic vasoconstriction, impair microcirculatory flow, and affect hemodynamics. This narrative review summarizes the physiological basis of oxygen as a cardiovascular intervention and discusses the evidence guiding oxygen use in acute coronary syndromes, cardiac arrest, postresuscitation care, acute heart failure, cardiogenic pulmonary edema, cardiogenic shock, cardiac surgery, and cardiac intensive care. Oxygen should be administered immediately when hypoxemia, respiratory distress, shock, cardiac arrest, or peri-intubation instability is present. After stabilization, the FiO2 should be reduced to maintain adequate oxygenation while avoiding supraphysiological arterial PaO2 (> 100 mm Hg). Bedside decisions could integrate peripheral oxygen saturation and PaO2 plus hemoglobin concentration, cardiac output, perfusion, lactate, acid–base status, respiratory effort, and the clinical trajectory. In cardiac critical care, oxygen should be prescribed as a titrated therapy with a clear indication, device, target range, monitoring plan, and criteria for escalation or de-escalation.
Autor:innen und Institutionen
- Hospital F. Spaziani, Department of Anesthesia and Intensive Care, Lazio, Italy, Frosinone.
- Hospital M.G. Vannini, Department of Anesthesia and Intensive Care, Lazio, Italy, Rome.
- CIBER de Enfermedades Respiratorias, Instituto de Salud, Carlos III, Community of Madrid, Spain, Madrid.
- Research Unit at Hospital Universitario Dr. Negrín, Fundación Canarias Instituto de Investigación Sanitaria de Canarias, Canary Islands, Spain, Las Palmas de Gran Canaria.
- Li Ka Shing Knowledge Institute, St. Michael's Hospital, Ontario, Canada, Toronto.
- Faculty of Health Sciences, Universidad del Atlántico Medio, Canary Islands, Spain, Las Palmas de Gran Canaria.
ORCID-Profile: Antonio Campanella, Riccardo Guglielmi
Förderung
- ERAPerMed
- Instituto de Salud Carlos III, Madrid, Spain
- European Regional Development Funds, Fundación Canaria Instituto de Investigación Sanitaria de Canarias, Spain
- Asociación Científica Pulmón y Ventilación Mecánica, Spain.
Zitieren
APA
Campanella, A., Guglielmi, R., Villar, J., & Ferrando, C. (2026). Oxygen Supplementation and Hyperoxia in Critically Ill Cardiac Patients. Seminars in Respiratory and Critical Care Medicine. https://doi.org/10.1055/a-2960-4026
Vancouver
Campanella A, Guglielmi R, Villar J, Ferrando C. Oxygen Supplementation and Hyperoxia in Critically Ill Cardiac Patients. Seminars in Respiratory and Critical Care Medicine. 2026. doi:10.1055/a-2960-4026
BibTeX
@article{Campanella2026,
author = {Campanella, Antonio and Guglielmi, Riccardo and Villar, Jesús and Ferrando, Carlos},
title = {Oxygen Supplementation and Hyperoxia in Critically Ill Cardiac Patients},
journal = {Seminars in Respiratory and Critical Care Medicine},
year = {2026},
doi = {10.1055/a-2960-4026}
}
EUVIMED